Experience of the use of liraglutide (Victoza) in women with type 2 diabetes mellitus and obesity
Aim. To study efficacy of treatment with liraglutide in women with type 2 diabetes (T2D) and obesity. Materials and methods. A group of 12 women aged 52-58 yr with T2D duration of 3-5 years, BMI 32-35 kg/m2, abnormally high C-peptide level,and НbА1с 7.5-8.5% were treated with 1500-2000 mg metformi...
Guardado en:
Autores principales: | Vladimir Ivanovich Kudinov, Natalya Vladimirovna Zolotareva, Maria Sergeeva Nichitenko |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aae89bec6f9d4226b7ae68f7f1b57120 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
por: Vladimir Ivanovich Kudinov, et al.
Publicado: (2012) -
First GLP-1 analog liraglutide: the result of clinical trails on efficacy
por: Alexander Sergeevich Ametov, et al.
Publicado: (2011) -
Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
por: Lyudmila Alexandrovna Ruyatkina, et al.
Publicado: (2017) -
Liraglutide for Weight Management in the Real World: Significant Weight Loss Even if the Maximal Daily Dose Is Not Achieved
por: Liesbet Trenson, et al.
Publicado: (2021) -
Clinical Impact of Liraglutide as a Treatment of Obesity
por: Alruwaili H, et al.
Publicado: (2021)